Drug General Information (ID: D1068)
  Drug Name
Miltefosine
  Drug Type Small molecule
  Drug Synonymous
HDPC; HePC; Hexadecylphosphocholine; Hexadecylphosphorylcholine; Impavido; Miltefosina; Miltefosinum; Miltex; Baxter Oncology brand of miltefosine; Baxter brand of miltefosine; Miltefosin C; Prasfarma brand of miltefosine; D 18506; IN1227; D-18506; H-1850; M-7200; Miltefosina [INN-Spanish]; Miltefosine (INN); Miltefosine[INN:BAN]; Miltefosinum [INN-Latin]; N-Hexadecylphosphorylcholine; TF-002; Choline hydroxide, hexadecyl hydrogen phosphate, inner salt; Choline, hexadecyl hydrogen phosphate, inner salt; Hexadecyl 2-(trimethylazaniumyl)ethyl phosphate; Choline phosphate, hexadecyl ester, hydroxide, inner salt; Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI); Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt; 1-Hexadecylphosphorylcholine; 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt; 3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide
    Click to Show/Hide
  Disease Class 1F54: Leishmaniasis
  Therapeutic Class Antifungal Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C21H46NO4P
  InChI 1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3
  InChIKey PQLXHQMOHUQAKB-UHFFFAOYSA-N
  Canonical SMILES CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
  External Link
Pubchem ID 3599
CAS Number 58066-85-6
CHEBI ID 75283
TTD ID D00FGR
INTEDE ID DR1092

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
AM006  Pharmacodynamic additive effects
BM009  Altered absorption (Unspecific)
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Miltefosine
      Affected gastrointestinal absorption
   Altered absorption (Unspecific) Drug Num:  8
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0450
 
Desogestrel
 
C22H30O
 
40973 
Moderate    Inter Info   
[1], [2], [3]
D0536
 
Drospirenone
 
C24H30O3
 
68873 
Moderate    Inter Info   
[3]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Moderate    Inter Info   
[1], [2], [3]
D0922
 
Levonorgestrel
 
C21H28O2
 
13109 
Moderate    Inter Info   
[3]
D0485
 
Dienogest
 
C20H25NO2
 
68861 
Moderate    Inter Info   
[1], [2], [3]
D1157
 
Norgestrel
 
C21H28O2
 
13109 
Moderate    Inter Info   
[3]
D1154
 
Norethisterone
 
C20H26O2
 
6230 
Moderate    Inter Info   
[1], [2], [3]
D1156
 
Norgestimate
 
C23H31NO3
 
6540478 
Moderate    Inter Info   
[1], [2], [3]
      Pharmacodynamic additive effects
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[4]
References
1 Bailey DG, Arnold JMO, Spence JD "Grapefruit juice and drugs - how significant is the interaction." Clin Pharmacokinet 26 (1994): 91-8. [PMID: 8162660]
2 Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
3 Product Information. Impavido (miltefosine). Paladin Therapeutics Inc, Wilmington, DE.
4 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.